Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TSPO | P30536 | 3/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
| ▸ | WNK1 | Q9H4A3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21165605 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165568 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165585 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165579 | 0.99 | ATM (0.38) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165646 | 0.99 | ATM (0.38) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165578 | 0.98 | ATM (0.39) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL25941547 | 0.98 | ATM (0.39) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165713 | 0.98 | ATM (0.39) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165594 | 0.98 | ALK (0.33) | KDM4EATML3MBTL1TSPOALK | |
| SCHEMBL21165593 | 0.97 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190221750-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190221750-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | CRY1, CRY2, MCM4 | KDM4E 3296/4885ATM 1310/4885L3MBTL1 2041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.